O

OliPass Corp
KOSDAQ:244460

Watchlist Manager
OliPass Corp
KOSDAQ:244460
Watchlist
Price: 1 651 KRW -13.92% Market Closed
Market Cap: 9B KRW

Operating Margin
OliPass Corp

-1 249.2%
Current
-2 352%
Average
-4.7%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 249.2%
=
Operating Profit
-8.6B
/
Revenue
686.9m

Operating Margin Across Competitors

No Stocks Found

OliPass Corp
Glance View

Market Cap
9B KRW
Industry
Biotechnology

OliPass Corp. develops biological products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2019-09-20. The firm principally manufactures and sells nonopioid analgesic, hyperlipidemia medicine, ocular angiogenesis inhibitor, duchenne dystrophy medicine, cancer immunotherapy medicine and other products. In addition, the Company researches, develops and sells functional cosmetics through the artificial gene platform technology.

Intrinsic Value
1 112.49 KRW
Overvaluation 33%
Intrinsic Value
Price
O
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 249.2%
=
Operating Profit
-8.6B
/
Revenue
686.9m
What is the Operating Margin of OliPass Corp?

Based on OliPass Corp's most recent financial statements, the company has Operating Margin of -1 249.2%.

Back to Top